Hologic, Inc. recalled 3,728 units of ThinPrep CytoLyt Solution on December 12, 2025. The recall follows the discovery of fungal contamination with Parengyodontium album. Patients and healthcare providers must stop using the affected products immediately.
Fungal contamination of affected lot with Parengyodontium album.
Patients and healthcare providers should stop using this device immediately. Follow the recall instructions provided by the manufacturer. Contact Hologic, Inc or your healthcare provider for instructions. Notification method: Letter
Get instant alerts for Health & Personal Care recalls
Be the first to know. Free instant alerts to your inbox.
ThinPrep CytoLyt Solution is a buffered cell wash solution used in medical procedures for the preparation of specimens. Healthcare providers rely on this product for accurate cytological analysis.
The presence of Parengyodontium album in the solution can lead to contamination, posing a risk of infection to patients during medical procedures.
This recall is not part of a broader industry pattern.
The recall impacts healthcare operations, potentially delaying procedures and requiring the immediate stoppage of use of the affected solution.
The catalog number and lot number can typically be found on the product label or packaging.
Expect a processing time of 4-6 weeks for refunds or replacements after contacting the manufacturer.
Keep copies of any correspondence, receipts, and photographs of the product as evidence.
The recalled product is ThinPrep CytoLyt Solution, catalog number 0236004, with lot number 5062EC. It is distributed nationwide across the United States. Specific identifiers include UDI: (01)25420045508405(17)270303(10)5062EC.
Not sure what to do next? Our guide walks you through the process step by step.
Read: What to Do When You Find a Recalled ProductGet instant alerts for recalls that affect you. Free forever.
Complaints have been received of systems developing loose, missing, or broken internal bolts over time.
Complaints have been received of systems developing loose, missing, or broken internal bolts over time.
It was identified that certain devices were being operated outside the validated and FDA-cleared display configuration due to user modification of the manufacturer-installed settings. Modifications included disabling Barco Application Appearance Manager (AAM), altering calibration and compliance parameters, and adjusting additional display-related settings. This field correction is being conducted to restore affected system to the validated configuration and reinforce proper use in accordance with the Operator's Manual.
Hologic, Inc. recalled 681,870 units of the Brevera Breast Biopsy System on December 15, 2025, due to presence of particulates that can enter breast tissue. The recall affects devices distributed nationwide in the U.S. Healthcare providers and patients must stop using the device immediately.